XBIONasdaq United States
Market cap
$7.263 M
$3.17 +11.23%
Close of 7 Aug 2026
Revenue
$2.98M
#3387 by revenue
Earnings
-$2.68M
Loss-making
Shares outstanding
2,343,181
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Xenetic Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.